Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Scher

Showing results (271-280 of 692) with videos related to

Pageof 70
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
Alterations affecting the p53 control pathway in bilharzial-related bladder cancerI Osman, H I Scher, Z F Zhang, et al.
Cellular Immunology|May 1, 1984
Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysisL M Wahl, I M Katona, R L Wilder, et al.
The Journal of Urology|February 21, 2017
Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical ProstatectomyNicola L Robertson, Evis Sala, Matthias Benz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan IndexM Imbriaco, S M Larson, H W Yeung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancerW K Kelly, I Osman, V E Reuter, et al.
Urology|July 13, 2004
Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancerCharles J Ryan, Michael J Zelefsky, Glenn Heller, et al.
Headache|April 21, 2007
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapyStephen D Silberstein, David Dodick, Fred Freitag, et al.
Cephalalgia : an International Journal of Headache|February 23, 2013
Haplotype analysis of the folate-related genes MTHFR, MTRR, and MTR and migraine with auraKathryn A Roecklein, Ann I Scher, Albert Smith, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1996
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onsetD O Hardy, H I Scher, T Bogenreider, et al.
Journal of Neurotrauma|July 27, 2011
MTHFR C677T genotype as a risk factor for epilepsy including post-traumatic epilepsy in a representative military cohortAnn I Scher, Holly Wu, Jack W Tsao, et al.
Pageof 70

Showing results (271-280 of 692) with videos related to

Sort By:
Pageof 70
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
Alterations affecting the p53 control pathway in bilharzial-related bladder cancerI Osman, H I Scher, Z F Zhang, et al.
Cellular Immunology|May 1, 1984
Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysisL M Wahl, I M Katona, R L Wilder, et al.
The Journal of Urology|February 21, 2017
Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical ProstatectomyNicola L Robertson, Evis Sala, Matthias Benz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan IndexM Imbriaco, S M Larson, H W Yeung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancerW K Kelly, I Osman, V E Reuter, et al.
Urology|July 13, 2004
Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancerCharles J Ryan, Michael J Zelefsky, Glenn Heller, et al.
Headache|April 21, 2007
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapyStephen D Silberstein, David Dodick, Fred Freitag, et al.
Cephalalgia : an International Journal of Headache|February 23, 2013
Haplotype analysis of the folate-related genes MTHFR, MTRR, and MTR and migraine with auraKathryn A Roecklein, Ann I Scher, Albert Smith, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1996
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onsetD O Hardy, H I Scher, T Bogenreider, et al.
Journal of Neurotrauma|July 27, 2011
MTHFR C677T genotype as a risk factor for epilepsy including post-traumatic epilepsy in a representative military cohortAnn I Scher, Holly Wu, Jack W Tsao, et al.
Pageof 70